Shingrix vaccine associated with reduced cardiovascular event risk

Researchers suggest the Shingrix shingles vaccine may provide cardiovascular protective benefits comparable to daily antihypertensive medication. The study highlights a potential secondary health benefit of the vaccine, though the underlying biological mechanism remains to be fully established.